# Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence

> **NCT07686861** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Cirrhosis With Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Bifidobacterium quadruple live tablets
- **DRUG:** Bifidobacterium quadruple live bacteria tablets placebo

## Key facts

- **NCT ID:** NCT07686861
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-02-28
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686861, "Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07686861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*